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Numerous exploratory, proof-of-concept and interven-
tional studies have used histaminergic and non-hista-
minergic human models of itch. However, no reliability 
studies for such surrogate models have been conduc-
ted. This study investigated the test–retest reliability 
for the response to histamine- and cowhage- (5, 15, 25 
spiculae) induced itch in healthy volunteers. Cowhage 
spiculae were individually applied with tweezers and 
1% histamine was applied with a skin prick test (SPT) 
lancet, both on the volar forearm. The intensity of itch 
was recorded on a visual analogue scale and self-re-
ported area of itch was assessed 5 and 10 min after 
itch provocation. Reliability of the evoked itch (area 
under the curve and peak intensity) was assessed by 
the coefficient of variation (CV), intra-class correla-
tion coefficient (ICC), and sample size estimation for 
parallel and cross-over designs. Cowhage (ICC = 0.57–
0.77, CVbetween = 97%, CVwithin = 41%) and histamine: 
(ICC = 0.83–0.93, CVbetween = 97%, CVwithin = 20%) ex-
hibited moderate-to-excellent intra-individual relia-
bility and moderate inter-individual reliability for the 
itch intensity. For a test–retest observation period of 
one week, SPT-delivered histamine and application of 
cowhage-spiculae are reproducible human models of 
itch. The high inter-individual and low intra-individual 
variability suggests cross-over designed studies when 
applicable.
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Itch, also known as pruritus, is defined as “an unpleasant sensation evoking a desire to scratch” (1, 2). Chronic 
itch (> 6 weeks (3)) is highly bothersome and is usually 
a manifestation of a disease, but can also occur without 
any obvious somatic causes. Chronic itch is often as-
sociated with decreased quality of life, insomnia, and 
attentional difficulties, and, in this respect, is similar 
to the well-known consequences of chronic pain (2, 4, 
5). Neurophysiologically, itch is conveyed by at least 2 
separate pathways; histaminergic itch is transmitted by 
nociceptive mechano-insensitive C-fibres (CMi) respon-
sive to, for example, histamine, while non-histaminergic 
itch is transmitted by polymodal nociceptive mechano-
sensitive C-fibres (PmC) responsive to, for example, 
mucunain from cowhage (6–8).
Histamine, which is by far the most studied pruri-
togen, excites the subset of pruriceptive CMi-fibres 
expressing H1R and H4R. CMi-fibres are peptidergic, 
terminate within and below the stratum granulosum 
of the epidermis, and have large receptive fields. As a 
result the activation of CMi-fibres is usually associated 
with the neurogenic axon-reflex (flare) (1, 2, 4, 9). His-
taminergic itch, e.g. in chronic urticaria, is generally 
responsive to antihistamines. However, a number of 
disorders causing chronic itch cannot be treated with 
antihistamines, underscoring the clinical importance of 
also understanding the non-histaminergic pathway of itch 
(7, 10–13). A distinct non-histaminergic pathway of itch 
is mediated by the protease-activated receptors (PAR2 
and PAR4) and transmitted through PmC- and Aδ-fibres 
with smaller receptive fields than CMi-fibres (14). PAR2 
is the prototypical human receptor associated with non-
histaminergic itch (10, 15, 16). Upon binding of a ligand, 
either exogenously or endogenously, a cleavage of PAR2 
occurs, as well as a co-activation of transient receptor 
potential anillin 1 (2, 10, 17, 18). The most frequently 
studied exogenous PAR2-agonist is mucunain, a cysteine 
protease found on the spiculae of the plant Mucuna pru-
riens, commonly known as cowhage. Cowhage spiculae 
activate the subset of pruriceptive fibres leading to the 
perception of both itch and mild pricking/stinging pain 
(3, 8, 13). The co-activation of Aδ-fibres should concei-
vable result in better spatial resolution and localizability 
of the non-histaminergic itch compared with histamin-
ergic itch (7, 19–23), but this has not been confirmed. 
This could theoretically parallel the findings in the area 
of pain, where Aδ-fibre-mediated pricking pain is well 
localized, whereas C-fibre-mediated burning pain is more 
diffuse (19–23). Pruriceptive primary afferents of both 
the histaminergic and non-histaminergic itch pathway 
are multimodal, in the sense that they are also capable of 
transmitting nociceptive signals in response to algogenic 
stimuli, such as capsaicin (24). 
The methods for induction of histamine- and cowhage-
induced itch have been based on numerous different 
application techniques (8, 15, 25), but very little is known 
about their test–retest reliability. Reliable, symptom- 
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Reliability of human models of itch
and mechanism-specific human and animal surrogate 
models are increasingly applied in biomedical research 
for several different purposes: (i) they provide a con-
venient, mechanism-based approach to profiling novel 
drug candidates in early clinical development; (ii) they 
can be used as provocation modalities to probe relevant 
patient populations for explorative, segmentational or 
diagnostic purposes or to test potential peripheral and 
central sensitization phenomena; and (iii) they can be 
readily applied for testing neurophysiological aspects 
of particular sensory symptomatology in animals and 
humans (3–5, 13, 26–30). Human surrogate itch models 
can also be applied to effectively guide the choice of the 
clinical study population in clinical trials, increasing the 
likelihood of a successful drug development (3, 5, 31). 
The present study aimed to assess the test–retest relia-
bility of histamine- and cowhage-induced itch, together 
with an assessment of potential differences in the spatial 
discrimination of itch evoked by cowhage and histamine.
MATERIALS AND METHODS 
Two 1.5 h study sessions were performed, approximately one 
week apart, on the same group of male volunteers. The order of 
itch provocations with cowhage and histamine, as well as arm 
dominancy was randomized. This order of itch provocation was 
established in the first experimental session and repeated in the 
second session. While the subjects were unaware of which itch 
provocations were being applied and were instructed to look away 
during the administration, unblinding could have occurred based 
on the different tactile sensations evoked during application. The 
regional ethics committee approved the experimental protocol 
(approval number N-20140078) and the experiments were con-
ducted at the Laboratory of Experimental Cutaneous Pain, Center 
for Sensory-Motor Interaction, Aalborg University in accordance 
with the principles of the Declaration of Helsinki (32). All parti-
cipants provided written and oral informed consent prior to study 
participation and were informed that they could withdraw from 
the study, at any time.
Subjects
Fifteen male caucasian subjects (age 24.07 ± 0.73 years) participa-
ted in the study. Inclusion criteria were healthy male subjects, in 
the age range 20–35 years. Exclusion criteria were: any history of 
neurological, musculoskeletal, mental, dermatological, or allergic 
disorders, as well as any other on-going itch or pain problems. 
Elicitation of itch with cowhage and histamine
Itch was induced in predefined application areas of the volar fo-
rearms of each subject. Three different arrangements of cowhage, 
using 5, 15, and 25 spiculae, as well as an application of histamine 
(1%) (Default Preparation, Diagenics, Bletchley, UK), were tested 
and compared (Fig. 1A). Application of the cowhage spiculae and 
histamine was randomized between the right and left arm. The 4 
areas used for cowhage and histamine application were next to the 
middle of the volar forearms measured from the wrist to the cubital 
fossa (Fig. 1B). Using this demarcation, one application area was 
marked 2.5 cm above the middle of the forearm and one area was 
marked 2.5 cm below. The 4 areas measured 1.5×1.5 cm and were 
marked with a metallic paint marker (054, Edding International 
GmbH, Ahrensburg, Germany). Cowhage spiculae were prepared 
immediately prior to application under a stereo-microscope (Seben 
Incognita, Seben GmbH, Berlin, Germany) using a negative-grip 
tweezer (Electron Microscopy Science, Dumont, Switzerland) to 
arrange and transfer spiculae to another set of up to 5 insertion 
tweezers (Wittex GmbH, Munich, Germany). Each of the prepared 
tweezers was loaded with 5 spiculae, approximately 1 mm apart, 
which permitted the insertion of 4 (±1) spiculae in the skin per 
tweezer. The spiculae were inserted in the skin (Fig. 1B) within a 
30 s interval and at an angle of approximately 45°, as described 
previously (33). The subjects did not observe the application of 
cowhage spicules or the skin prick test (SPT) lancet introduction 
of histamine. After 15 min the spiculae were removed with tape. 
A microdermascope (DinoLite, AnMo Electronics Corporation, 
Naarden, The Netherlands) was used to capture magnified images 
of the cowhage spiculae applied to the skin, and to validate that 
an acceptable amount of spiculae had been inserted successfully 
(±20% of intended spiculae). The images were analysed with 
the proprietary manufacturer software (DinoCapture 2.0, AnMo 
Electronics Corporation).
Histamine was applied with an SPT lancet (Allergopharma, 
Diagenics, Bletchley, UK) and a pressure of 120 g, using a SEN-
SEBox electronic von Frey transducer (SENSEBox EvF, Somedic 
AB, Hörby, Sweden), with an attached custom-made prick lancet 
mount (Aalborg University, Aalborg, Denmark). The controlled 
pressure applied was aimed at increasing reliability and based on 
an initial pilot study showing that 120 g was sufficient to establish 
a wheal > 3 mm in diameter in all participants, while minimizing 
the occurrence of bleeding (34, 35). Histamine application using 
weight-controlled SPT was chosen as a comparator, instead of, 
for example, iontophoresis, intradermal injections or inactivated 
histamine-coated spiculae for several reasons: (i) SPT application 
of histamine has been reported to produce a stronger and more 
lasting itch sensation than iontophoresis and is associated with less 
pain and discomfort than intradermal injections (36, 37); (ii) it is 
the most commonly studied approach, while being easy, safe and 
clinically applicable (e.g. compared with coated spiculae and intra-
dermal injections) (38); (iii) it requires a minimum of equipment 
and thus the method can easily be applied in any setting in future 
studies; (iv) compared with intradermal injection and iontophore-
sis, SPT application resembles that of spiculae, in that the applied 
substance is mainly brought into contact with the epidermis and 
the dermoepidermal junction in a very localized manner. 
Fig. 1. Experimental design. (A) Positioning of the application areas 
for itch induction with cowhage and histamine on the volar forearm. (B) 
Approximate placement of the cowhage spiculae and histamine in each 
application area. In area 4 a droplet of histamine was applied and introduced 
intra-epidermally using a lancet prick. Each area measured 1.5×1.5 cm.
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Outcome measures 
Assessment of experimentally-induced itch and pain intensity. 
The intensity of the elicited itch was assessed every 20 s for 10 
min, from the moment of application, using a computerized visual 
analogue scale (VAS). The VAS ranged from 0 = ”no itch” to 10 = 
”worst imaginable itch” with a label at 50% of its length, labelled 
“strong urge to scratch”. Similar VAS modifications were used 
in the studies by Mørch et al. (39) and Hartmann et al. (13). The 
subjects were instructed to rate the sensation of itch by using the 
50% mark as a guideline. Simultaneously to itch rating, the pain in-
tensity of 2 sensory descriptors “pricking/stinging” and “burning” 
were reported for 10 min using 2 similar VASs with a sampling 
rate of 1/min. The VAS intensity for “pricking/stinging” allowed 
ratings from 0=”no pricking/stinging” to 10=”worst imaginable 
pricking/stinging pain”. Likewise, the VAS for the burning pain 
allowed ratings from 0 = ”no burning” to 10 = “worst imaginable 
burning pain”. Both scales for nociceptive sensory qualities had 
identical 50% marks labelled “strongly painful sensation” analogue 
to the 50% label on the scale applied for itch sensation.
Localization and spatial distribution of induced itch. Navigate 
Pain software (Aalborg University, Aalborg, Denmark) was used 
to record the location and area of itch experienced by each sub-
ject 5 and 10 min after each itch provocation. This method has 
previously been validated and comparatively analysed matched to 
traditional hard-copy pain drawings in pain patients and healthy 
controls (40). The subjects were specifically instructed to: (i) draw 
the area where they felt itch on a 3D body schema representing 
the left or right volar forearm similar to the arm schema (Fig. 
1A), (ii) disregard the area where the spiculae or the histamine 
had been applied which was visually observable during the VAS 
recordings, and (iii) focus only on the perceived area of itch. The 
percentage of the drawn area vs. the total arm area was multiplied 
by 2 to account for the fact that the applied body schema showed 
both volar forearms. Finally, the spatial distribution was obtained 
by superimposing the perceived areas of itch for each of the 4 itch 
provocations, at 5 and 10 min.
Statistical analysis
The software SPSS Statistics version 22 (IBM corporation, Red-
mond, USA) was used to analyse all data and to assess statistical 
significance. A significance level at p ≤ 0.05 was chosen, marked 
with (*) in the results section, while highly significant differen-
ces with p ≤ 0.01 are marked with (**). Descriptive parameters; 
arithmetic mean and standard error of the mean (SEM) were 
calculated for all reported parameters and are shown in the results 
section unless specifically stated otherwise. Visual inspection and 
confirmatory Shapiro-Wilk’s tests were performed to ascertain the 
normality of the data. For all parameters recorded with the VAS, 
the area under the curve (AUC) was calculated and the peak itch 
intensity was noted for every subject in response to each of the 
4 itch provocations (5, 15, 25 spiculae and 1% histamine) and at 
each session. The itch AUC, the peak itch intensity and the per-
ceived area of itch from the 2 sessions were tested by 2 repeated 
measures analysis of variance (ANOVAs) (exposure; 4 levels, 
outcome; 2 levels, session; 2 levels) followed by Fischer’s test of 
least significant difference for pairwise post hoc comparisons. The 
main effect of sessions was used to ascertain whether a bias was 
present between data-sets obtained from session 1 vs. session 2. 
Correlation analyses were conducted using the Pearson product-
moment correlation coefficient between the reported itch areas at 
5 or 10 min and the peak itch intensity/AUC and itch intensity at 
5 min. Correlations were assessed within each itch provocation 
condition (i.e. n = 15) and across all 4 conditions for each session 
(i.e. n = 60). 
Reliability statistics 
To estimate the reliability between the 2 sessions the intra-class 
correlation coefficient (ICC) and the coefficient of variation (CV) 
were calculated. In addition, the estimated minimum sample sizes 
for parallel and cross-over studies were calculated and Bland-
Altman plots were produced. To evaluate the relative reliability 
between the 2 sessions the ICC (model 2,1; randomly selected 
raters and single measurements) for absolute consistency was 
used. Further information is available on different ICC models 
elsewhere (41–43). The ICC was calculated for each of the 4 app-
lied itch provocations for the parameters itch AUC and peak itch 
intensity. ICC values ranging from 0.5 to 0.75 were considered 
moderate, while values > 0.75 are considered excellent (44). In the 
calculations of CV and ICC values, subjects who rated zero in both 
sessions were excluded from reliability calculations pertaining to 
that particular condition (i.e. 3 subjects for the 5 spiculae condition 
and 1 subject for 15 spiculae condition). This was done to avoid 
artificially inflating the produced measures of intra-individual 
reliability in the lower stimulus intesity conditions, where zero was 
occasionally rated in both sessions. One significant outlier (subject 
number 6, 15 spiculae condition) was excluded from further relia-
bility assessments. The data from subjects are included in all other 
analyses. CV was calculated both within- and between-sessions, 
signifying inter- and intra-individual measurements, respectively. 
The following equations were used (their respective theoretical 
frameworks are elaborated upon in (39, 45))
where SD represents the standard deviation and μ the mean for each 
session. For potential future use in clinical or exploratory studies 
minimally required sample size estimations were performed using 
the data obtained from each of the 4 itch provocations (5, 15, 25 
spiculae, and 1% histamine). Using the following equations, the 
minimal amounts of participants in future parallel and cross-over 
studies were calculated. The power (1–b) was set to 0.8 and the 
significance level (a) at 0.05, using the standard textbook value 
(2×7.8=15.6) at the relevant α and β-levels (46, 47). The relevant 
detectable effect (E) was estimated as a 50% reduction of the 
mean itch intensity (itch AUC or peak itch intensity) averaged 
between sessions 1 and 2. 
Bland-Altman-plots were produced to illustrate possible varia-
tions between the sessions, variations between the 4 itch provo-
cations, outliers, and potential systematic biases. The difference, 
as calculated by subtraction of session 1 from session 2 for each 
parameter, was compared with the mean. 
RESULTS
All of the 15 male subjects enrolled in this study com-
pleted both of the experimental sessions. The 2 sessions 
were conducted with 7.73 ± 0.83 days in between. No 
significant main effect of session was found pertaining 
to induced itch: F (1, 14 = 0.073, p = 0.791) or itch areas: 
F (1, 14=1.54, p = 0.235), indicating no significant bias 
between experimental sessions. 
Within session CV = SD 100 
 
Between session CV =       SD differenc             100
 
(( session1+ session2)) 
2
nparallel = 15.6 SD
2 
 
E2 
Ncrossover = 15.6 SD
2 (1 – ICC) 
E2 
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Reliability of human models of itch
Itch intensity and pain sensations
No statistical differences in itch AUC or peak itch in-
tensity were detected between the 2 sessions for neither 
histamine nor cowhage. Distinct 10 min temporal itch 
intensity profiles were recorded in response to the 4 itch 
provocations in each of the 2 sessions (Fig. 2). Peak itch 
intensity was achieved 2–4 min after both cowhage and 
histamine applications with the histamine-induced itch 
exhibiting a slower decline than cowhage. The 3 applica-
tions of cowhage (5, 15, and 25 spiculae) exhibited dose-
responsiveness, both in terms of itch intensity AUC and 
itch peak intensity, with the 5 spiculae and the 25 spiculae 
applications being significantly different (p < 0.01 and 
p < 0.05, respectively; Fig. 2E). While a significant dif-
ference was found between the 5 spiculae condition and 
1% histamine for the peak itch intensity (p < 0.05), the 
1% histamine and the 25 spiculae, produced similar indi-
vidual itch peak intensities at 4.09 ± 0.76 and 4.07 ± 0.77, 
respectively (p > 0.9) (Fig. 2F). The histamine resulted 
in significantly higher itch AUC values than any of the 
cowhage conditions (p < 0.05). 
The recorded pricking/stinging peak VAS intensities 
were in mean 1.07 ± 0.29 for all 3 cowhage applications 
and 1.44 ± 0.37 for histamine averaged between sessions. 
The temporal VAS profiles are shown in Fig. 2. Not all 
subjects experienced the itch provocations as pricking/
stinging and the frequency of reports differed between 
conditions, e.g. in session 1 after application of 25 spi-
culae, 14/15 subjects reported some presence of pricking/
stinging, while after application of 5 spicules only 6/15 
subjects reported these sensations. For burning, the in-
tensities reported were very low: 0.38 ± 0.26 for cowhage 
and 0.42 ± 0.24 for histamine (data not plotted), and only 
6 of 15 subjects employed the “burning” quality during 
the course of the study. Lastly, several participants spon-
taneously reported that cowhage-elicited itch and pain 
sensations occurred in intense “on/off” bouts; however, 
this was unquantifiable in the present study design.
Spatial discrimination of cowhage- and histamine-
induced itch
The size of the reported perceived areas of itch exhibited 
high intra- and inter-individual variation. No significant 
differences were found for the perceived areas of itch 
between the sessions for any of the itch provocations 
with or without pooling data from 5 and 10 min drawings 
and sessions. The area of perceived itch to cowhage 
was significantly larger at 5 min compared with 10 min 
after application (for pooled sessions and conditions) 
(p < 0.05), while no differences were observed for the 
size of the histamine-induced areas of itch at 5 min 
compared with 10 min after application for unpooled 
and pooled sessions (Fig. 3A). Moreover, no significant 
differences were found between the spatial distribution 
of cowhage- and histamine-evoked itch for any of the 
4 applications including at similar peak intensities, i.e. 
between the 25 spiculae and the histamine applications 
(Fig. 4B). 
Overlays of the spatial distributions of perceived itch 
are presented for 5, 15, 25 spiculae, and 1% histamine, 
with the 2 sessions being pooled (Fig. 4). As is apparent 
from Fig. 4A, the perception of low-intensity itch (5 
spiculae) was difficult for the subjects to localize. No 
significant correlations were found between the perceived 
areas of itch and the rated itch intensity (AUC, peak or 
intensity at 5 min) within the individual provocations. 
Analyses across all 4 conditions in each of the 2 sessions 
yielded significant positive correlations between area size 
and itch intensity at 5 min in session 1: ρ = 0.27, p < 0.05, 
n = 60, and in session 2: ρ = 0.42, p < 0.01, n = 60. 
Reliability of the applied models of itch 
Table I shows the values of within-sessions CV, between-
sessions CV, ICC values between sessions and estimated 
minimum sample sizes for the induced itch, measured 
as itch AUC and peak itch intensity. The inter-individual 
variation is generally high for induced itch, whereas the 
Fig. 2. Comparative figures of the temporal visual analogue scale (VAS) intensity for itch and “pricking/stinging” pain for each of the 4 
itch provocations in session 1 and 2 (A: 1% histamine, B: 25 spiculae, C: 15 spiculae and D: 5 spiculae). VAS recordings of “burning” pain intensity 
are not included. (E) Mean of session 1 and 2 for AUC of itch intensity for each itch provocation. (F) Average of session 1 and 2 for VAS-peak of itch 
intensity for each itch provocation. Mean ± standard error of the mean (SEM), *p < 0.05, **p < 0.01.
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intra-individual variation is relatively low. All tested itch 
provocations exhibited moderate-to-excellent reliability 
estimated by ICC calculation. For the 5, 15 and 25 spi-
culae applications ICC-values ranged from 0.63 to 0.77 
for itch AUC, and 0.57 to 0.72 for peak itch intensity, 
without coherence in terms of the influence of the number 
of spiculae inserted. However, the itch induced by 1% 
histamine yielded better ICC values than for the cowhage 
applications, i.e. 0.83 for itch AUC and 0.93 for peak 
itch intensity. Parameter comparison between itch AUC 
and peak itch intensity from 10 min recordings showed a 
better performance for achieving low and intra-individual 
variability by measuring individual peak itch intensity 
over itch AUC. 
The within-sessions CV values showed stimulus-
intensity-dependent improvements in absolute reliability, 
i.e. lower CV values for itch provocations associated with 
more intense itch (such as 25 spiculae or 1% histamine). 
A similar trend was observed for between-sessions CV 
values, indicating that increasing the stimulation intensity 
can reduce both intra- and inter-individual variability (Ta-
ble I). For absolute reliability measured by CV within both 
sessions, the peak itch intensity parameter was superior 
to the itch AUC, with a CV across all itch provocations, 
which was, in mean, 22.24 ± 3.77% lower. This resulted 
in proportionally lower minimum required sample sizes 
for cross-over studies compared with parallel designs. 
The Bland-Altman difference plots (Fig. 5) illustrate 
the level of agreement between the 2 sessions for itch 
AUC and peak itch intensity. The difference plots showed 
no evidence of a fixed or proportional bias. The Bland-
Altman plots for peak itch intensity showed a smaller 
mean difference than for itch AUC for all itch provoca-
tions, indicating a better between-session consistency for 
peak itch intensity, especially between 25 spiculae and 
1% histamine (Fig. 5). 
DISCUSSION
The present study showed that insertion of 5, 15, or 25 
cowhage spiculae and intra-epidermal delivered 1% 
histamine resulted in moderate-to-excellent relative re-
liability and moderate absolute reliability of the evoked 
itch responses. The overall reliability was best for the 
provocations causing higher itch intensities. A total of 
25 spiculae evoked itch with a peak itch intensity com-
parable to that of 1% histamine. No differences were 
detected in the sizes of the itch areas reported for any of 
the itch provocations. The study provides the basis for 
calculating sample sizes for parallel or cross-over study 
designs employing human models of itch. Based on the 
reliability assessed here, cross-over designs are recom-
mended whenever possible. 
Fig. 3. (A) Mean of session 1 and 2 of the total area of perceived itch 
(in % of total arm chart) at 5 and 10 min for 1% histamine and the 3 
cowhage applications averaged. (B) Mean area of perceived itch (in % of 
total arm chart) pooled between sessions and time points (5 and 10 min) 
for each of the 4 itch provocations (5, 15, 25 spiculae and 1% histamine). 
Mean ± standard error of the mean (SEM), *p < 0.05.
Fig. 4. Overlays for the overall spatial distribution and localization of itch for each of the applied itch provocations. A: 5 spiculae, B: 15 
spiculae, C: 25 spiculae, and D: 1% histamine. Sessions 1 and 2 are pooled.
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Sensory responses to histamine and cowhage
The temporal itch intensity profiles, evoked in response to 
the 4 itch models, are well aligned with previous research 
in terms of peak itch intensity and time course (8, 11, 13, 
31). The peak itch intensity was generally reached within 
2–4 min after administration and cowhage-induced itch 
exhibited a more rapid decrease than that of histamine, 
also in accordance with some of the previous findings (8, 
48, 49). However, it should be noted that some previous 
studies have utilized a method of rubbing 40–45 spicules 
onto a larger skin area (11, 48, 50), and that, in some of 
these studies, this method is reported to produce a more 
intense itch (peak VAS ≈ 6–7) with less latency, which is 
probably associated with the application technique (11, 
50). These discrepancies in the literature regarding the 
magnitude and quality of cowhage-evoked psychophy-
sical responses highlight the problem of comparability 
between studies utilizing the cowhage model and stan-
dardizability of the model itself. Importantly, the model 
is reliant on diverse, untested plant material sourced from 
very different conditions across the world (9). 
The 3 cowhage itch provocations caused stimulus-
intensity dependent responses measured by itch AUC 
and peak itch intensity, as previously suggested (51, 52), 
whilst 25 spiculae and 1% histamine elicited very similar 
peak itch intensity. The SPT-delivered 1% histamine 
gave rise to a much longer-lasting itch than any of the 
cowhage applications, also in accordance with previous 
observations (11, 31). 
These characteristic time/intensity profiles of itch 
induced by histamine and cowhage closely mimic the 
temporal profile of discharge rates recorded from his-
tamine (53) or cowhage-responsive spinothalamic tract 
(STT) units in monkeys when their receptive fields were 
probed with histamine or cowhage, respectively (54). 
Previous studies on cowhage- and histamine-induced 
itch have reported that the sensation of itch frequently 
occurs together with pricking/stinging and burning pain 
Fig. 5. Bland-Altman difference plots. (A) itch visual analogue scale area under the curve (VAS AUC) and (B) itch VAS peak of itch intensity for each 
of the applied itch provocations (5, 15, 25 spiculae and 1% histamine), containing limits of agreement (meandifference± 1.96 SDdifference). Solid line represents 
mean difference between sessions and the dashed lines the limits of agreement.
Table I. Overview of reliability metrics for cowhage- and histamine-induced itch
Absolute reliability Relative reliability Minimum estimated sample size
Within session 
1 coefficient of 
variation 
%
Within session 
2 coefficient of 
variation 
%
Coefficient of 
variation between 
sessions 
%
Intra-class 
correlation 
coefficient (2,1)
Cross-over 
design Parallel design
AUC of visual analogue scale itch intensity
5 spiculae 114.99 141.65 53.61 0.63 31 96
15 spiculae 129.32 96.17 42.03 0.66 26 78
25 spiculae 84.15 89.68 42.58 0.77 11 48
1 histamine 86.94 95.55 25.43 0.83 9a 52
Visual analogue scale itch peak intensity
5 spiculae 107.16 120.48 40.25 0.72 23 78
15 spiculae 89.41 81.64 36.18 0.57 20 45
25 spiculae 48.26 67.70 33.79 0.68 12 21
1% histamine 68.56 77.31 15 0.93 3a 33
aIt may not be advisable to use there herein applied methods for elicitation of itch with n < 10 subjects regardless of the study design. 
Absolute reliability, relative reliability and estimated sample size for itch area under the curve (AUC) and peak itch intensity. Notice that the minimum estimated sample 
size is a theoretical value based on calculations explained in methods section.
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(3, 13, 51). The present study also showed pricking/sting-
ing pain after both cowhage and histamine application, 
although not to the same extent as some previous publica-
tions (13, 33). In addition, very low levels of burning pain 
were observed and generally reported to be slightly lower 
than in previous studies (3, 13, 51). In the present study, 
9/15 subjects never reported burning pain in response 
of any of the itch provocations across both sessions. 
These discrepancies may be caused by methodological 
differences relating to delivery method of histamine and 
cowhage, applied pain quantification scale, sampling 
frequency, and participants (who were exclusively male 
in the present study (55, 56)). Cowhage spiculae and, to 
a lesser extent, histamine have previously been described 
as eliciting itch occurring in “on/off” burst sensations 
(57), which was also reported by several subjects in this 
study. Notably, this on/off psychophysical scoring of itch 
sensation appears to correspond to observations made 
on primary afferents using microneurography, where 
cowhage spiculae in particular provoke a characteristic 
bursting pattern, with discharge frequencies during the 
burst of ≈0.5–5 Hz and silent intervals between bursts 
of ≈10 s (15, 58). 
Assessment of the cowhage- and histamine-induced itch 
areas
Since PmC/Aδ-fibres (conveying cowhage-induced itch) 
have much smaller receptive fields and are more densely 
distributed than CMi-fibres (conveying histaminergic 
itch) (24, 25, 49), we hypothesized that itch induced by 
cowhage would permit higher spatial discriminatory re-
solution than itch induced by histamine. A previous study 
suggested that histaminergic itch is less localizable and 
expands over a larger area than cowhage-induced itch, 
in line with the theoretical spatial resolution of CMi- 
and Aδ/PmC-fibres. However, this observation was not 
quantified (7). In the present study, the analysis did not 
reveal a significantly larger area of itch perception for 
histamine than for cowhage, as previously suggested. It is 
unclear why cowhage-induced itch, which is in part Aδ-
fibre driven, does not result in a more spatially confined 
and localizable itch area than that of histamine, which is 
conveyed via CMi-fibres, as this has been shown for Aδ- 
pricking and C-fibre burning pain (19–23). A potential 
confounding factor could be the initial mechanical stimu-
lation associated with the application of cowhage and his-
tamine and, in lieu of the high variability of the reported 
itch areas, it could be that the present study did not have 
adequate statistical power to detect such a difference. 
In addition, the bursting nature of the cowhage-induced 
itch sensation may have further decreased the reliability 
of the assessment, and it should be noted that the itch 
areas were not quantified during peak itch intensity, but 
always at 5 and 10 min after the itch provocations. In 
particular, for the cowhage-induced itch, which typically 
wears off more quickly than histamine-induced itch, this 
resulted in several area drawings being produced when 
the concurrent itch sensation was low. However, a non-
quantified tendency towards more anatomically accurate 
localization of the areas of itch was observed for provo-
cations eliciting more intense itch, i.e. 25 spiculae or 1% 
histamine, as opposed to 5 spiculae, despite the fact that 
these areas were not significantly smaller. While in the 
present study, the subjects did not observe the application 
of cowhage spicules or the SPT lancet introduction of 
histamine, both procedures are unavoidably associated 
with brief tactile/painful stimulation of the insertion area. 
Repeated vs. single insertion of spiculae, i.e. in the 5 vs. 
25 spiculae conditions, may have produced the tendency 
towards more accurate localization of the areas of itch 
produced by 25 spiculae on the basis of more tactile noise 
rather than itch sensation even though the area drawings 
were recorded 5 min after itch provocations. 
Sensory spatial characteristics and acuity of expe-
rimentally evoked itch and chronic itch occurring in 
patients (59) is a sparsely studied subject and it is metho-
dologically difficult to assess without introducing biasing 
tactile stimuli. A study by Wahlgren & Ekblom (60) 
explored the 2-point discrimination of itch stimuli using 
histaminergic itch provocations and found exceedingly 
poor spatial acuity compared with what is established for 
tactile and, more recently, also for pain stimuli (60, 61). 
Reliability of surrogate models of itch
Test–retest reliability studies have previously been per-
formed for different human surrogate models of pain 
and hyperalgesia, e.g. the ultraviolet B (UVB)-model 
of cutaneous hyperalgesia, the capsaicin model of se-
condary hyperalgesia or the L-menthol model of cold 
allodynia (29, 39, 62–64). Previously, the methods for 
induction of histaminergic and non-histaminergic itch 
have been based on a variety of different approaches to 
application (8, 15, 25), and have not been assessed for 
test–retest reliability. The lack of knowledge on test–re-
test performance decreases: (i) accurate power/sample-
size calculation, (ii) usefulness of surrogate models of 
itch for antipruritic drug candidate screening, and (iii) 
comparability between studies applying models of itch. 
In line with the present study, human surrogate models 
of itch, in general, exhibit high inter-individual variability 
(9, 13, 65). Moreover, in accordance with previous stu-
dies (33, 51), it was found that larger amounts of cowhage 
spiculae inserted into the skin resulted in more intense 
itch. Not previously explored, the present study revea-
led that itch induced with either cowhage or histamine 
was characterized by high test–retest reliability within 
individual subjects and that itch provocations evoking 
higher itch peak intensities were characterized by bet-
ter test–retest reliability. It is plausible that application 
of even more spiculae, e.g. 40–45 or even 70–100 as 
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used in some previous studies, would further improve 
reliability outcomes (5, 11, 48, 50). Along these lines, 
administration of a range of concentrations of histamine, 
e.g. by the use of intra-dermal injections, would have 
clarified whether histamine-induced itch also exhibits 
better test–retest reliability when more vigorous respon-
ses are evoked. 
The high variability in itch intensity ratings between 
subjects is conceivably attributable to the following 
factors: (i) central or peripheral individual differences in 
the neurophysiological processing of itch, i.e. a result of 
different physiological susceptibility to itch induced by 
the utilized substances (33, 51); and (ii) methodological 
variations in relation to the amount of inserted spiculae, 
variations in skin thickness (resulting in different penetra-
tion depth of the spiculae) or personality traits (9, 51). As 
with all psychophysical studies relying on self-reporting 
of sensory experiences, variation could, in part, be a re-
sult of diverse interpretations of the VAS, thereby ensuing 
in dissimilar ratings of itch between subjects resulting 
in large inter-subject, but not intra-subject, variation. 
Although the amount of spiculae applied to the skin was 
tightly controlled by using a digital micro-dermascope, 
it was not possible to accurately assess the penetration 
depth and angle in the epidermis. Previous studies have 
asserted that cowhage spiculae should be inserted near 
the basal membrane of the epidermis or at least into the 
stratum granulosum in order to evoke a sensory response 
(66). In addition, it has been suggested that in order to 
elicited a neuronal excitation of pruriceptive fibres the 
spiculae must be inserted adjacent to a nerve terminal 
(8, 57), which is less likely to occur when applying very 
few spiculae (33). On the other hand, a previous study 
found that insertion of a single cowhage spicule produ-
ced itch in 80% of all subjects (10), suggesting that the 
cowhage spiculae application is generally a robust ap-
proach. Lastly, 2 findings counter the notion of spiculae 
insertion variability as a major issue for model reliabi-
lity: (i) a considerable effect should also be observable 
for measures of relative reliability measures, which is 
not the case; (ii) a detectable, albeit small, micro-flare 
reaction was generally observed post-application for 
all subjects, even those reporting no or very low itch in 
response to cowhage, indicating adequate insertion of 
physiologically active spiculae. Thus, individual neu-
rophysiological or psychophysical differences should 
explain the majority of the observed variability. In the 
present study a highly homogenous group of young 
healthy male caucasian subjects was recruited to match 
typical conditions of phase 1 proof-of-concept studies 
in early drug development. It is highly conceivable that 
at least higher inter-individual disagreement would be 
present in a more diverse sample composition, i.e. on 
parameters such as gender, age, ethnicity and morbidity. 
Another finding pertaining to the reliability assessment 
was that peak itch intensity generally performed better 
than itch AUC, both in terms of absolute and relative 
reliability. These are both very common outcome mea-
sures for quantifying itch in response to a pruritogenic 
stimulus and/or a potential intervention (11, 50, 65, 67, 
68), and both measures can easily be assessed in most 
study designs. However, since peak itch intensity does 
not convey information about the temporal profile of the 
perceived itch (which is important in a clinical context), 
it may be less relevant as a primary outcome measure and 
could be exchanged for itch AUC. Moreover, based on 
the herein proposed sample size calculations adjusted by 
the obtained ICC values it would not drastically increase 
the minimum required sample size to use itch AUC ins-
tead of peak itch intensity in studies where a cross-over 
design is possible. 
Conclusion
The present study is the first to assess and compare the 
test–retest reliability of human surrogate models of 
itch. Cowhage application using negative-grip tweezers 
and application of histamine with an SPT lancet and a 
pressure of 120 g showed moderate-to-excellent intra-
individual test–retest reliability and moderate inter-
individual reliability. Itch provocation with 1% histamine 
and, to a lesser extent, insertion of 25 spiculae proved 
to have the best intra-individual test–retest reliability 
in a 1-week observation period. Moderate inter-subject 
reliability and moderate-to-excellent intra-subject relia-
bility favour cross-over study designs. The extent of the 
perceived area of itch did not differ between cowhage- 
and histamine-induced itch and, generally, the variability 
for this parameter was high.
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